Correction to: Cell Research (2014) 24:820–841. doi:10.1038/cr.2014.59; published online 9 May 2014
The protocol in the current study was developed using BIO as the GSK-3β inhibitor and works with other inhibitors as well. The strength and specificity of inhibition can increase efficiency of Phase I. The authors apologize for the mistyped GSK-3β inhibitor that was used in these studies. We would like to correct this immediately, which is noted only in three sentences in separate places in the paper. This does not impact on any of the results or the protocol mentioned in the paper and the results stand as is.
— (P 823, right column, line 5-7) “Treatment with the GSK-3β inhibitors BIO (6-bromoindirubin-3′-oxime; Sigma) or CP21R7 (Roche) in phase 1...” should be “Treatment with the GSK-3β inhibitor BIO (6-bromoindirubin-3′-oxime; Sigma) in phase 1...”.
— (P 824, left column, line 3-7) “We also found that CP21R7 had more stable results unaffected by its lot number, compared to BIO, and therefore, we basically used CP21R7 as a GSK-3β inhibitor in phase 1 in the following experiments.” should be deleted.
— (Supplementary information, Table S1, line 27) “GSK-3β inhibitor (BIO/CP21R7) [1uM/5uM]” should be “GSK-3β inhibitor (BIO) [5uM]”.
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/cr.2014.59
Rights and permissions
About this article
Cite this article
Sahara, M., Hansson, E., Wernet, O. et al. Erratum: Manipulation of a VEGF-Notch signaling circuit drives formation of functional vascular endothelial progenitors from human pluripotent stem cells. Cell Res 25, 148 (2015). https://doi.org/10.1038/cr.2015.2
Published:
Issue Date:
DOI: https://doi.org/10.1038/cr.2015.2
This article is cited by
-
Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions
Heart Failure Reviews (2023)
-
Retinoic acid inhibits the angiogenesis of human embryonic stem cell-derived endothelial cells by activating FBP1-mediated gluconeogenesis
Stem Cell Research & Therapy (2022)
-
High-efficient serum-free differentiation of endothelial cells from human iPS cells
Stem Cell Research & Therapy (2022)
-
Stem Cell Sources and Graft Material for Vascular Tissue Engineering
Stem Cell Reviews and Reports (2018)